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Available online 10 November 2016Anthropological studies based on the highly polymorphic gene, human leukocyte antigen (HLA), provide useful in-
formation for bone marrow donor registry, forensic medicine, disease association studies, as well as infertility
treatment, designing peptide vaccines against tumors, and infectious or autoimmune diseases. The aim of this
study was to determine HLA-A and HLA-B allele frequencies in 100 unrelated Lak/lᴂk/individuals from Lorestan
province of Iran. Finally, we compared the results with that previously described in Iranian population. Commer-
cial HLA-Type kits from BAG (Lich, Germany) company were used for determination of the HLA-A and HLA-B al-
lele frequencies in genomic DNA, based on polymerase chain reaction with sequence speciﬁc primer (PCR-SSP)
assay. The differences between the populations in distribution of HLA-A and HLA-B alleles were estimated by
chi-squared test with Yate's correction. The most frequent HLA-A alleles were *24 (20%), *02 (18%), *03 (12%)
and *11 (10%), and themost frequent HLA-B alleles were *35 (24%), *51 (16%), *18 (6%) and *38 (6%) in Lak pop-
ulation. HLA-A*66 (1%), *74(1%) and HLA-B*48 (1%), *55(1%) were the least observed frequencies in Lak popula-
tion. Our results based on HLA-A and HLA-B allele frequencies showed that Lak population possesses the















Among the basicmedical sciences involving in anthropology, immu-
nology can be considered as a science which deals with the molecular
markers playing role in recognition of self and non-self between ethnic-
ities [1]. So biomedicine is not alien to anthropology and offers an eth-
nographic international classiﬁcation of ethnicities based on the
immunological molecules such as CDmarkers [2,3]. Hereby the integra-
tionbetween anthropology and immunology as a kindof integration be-
tween social and medical sciences could be a strategic way to have a
biological information bank of different cultures in order to reach the
aimsmentioned in the next such as bonemarrow transplantation, infer-
tility prognosis and treatment [4,5] and ﬁnding the identity of persons






cle under the CC BY-NCIn the mankind genome, the human leukocyte antigen (HLA) also
called as major histocompatibility complex (MHC) [6] with the length
of 3600 kb is located on chromosome 6 and includes 239 antigenic
loci that about 40% of them are immunogenic [7]. Recently, N2000
alleles for HLA class I are known in humans [8]. There are 2 classes
of HLA and HLA class I in turn falls in two categories of classical
(HLA-A and B) and non-classical (HLA-C, G, E and F) [4,9–13]. The
main role of HLA class I is that this biological molecule acts as an
identifying card for all nuclear cells of body to be proposed for
natural killer cells (CD56CD16 [14]) that different interactions be-
tween them results in different outcomes [15]. In addition to the
key roles considered by immunologists for HLA, such genes have
attracted the view point of most developmental biologists because
of a high level of allele variety.
Since some alleles of HLA are commonplace in speciﬁc populations,
the alleles are used by anthropologists as markers to determine genetic
correlations and interactions in different populations [2]. Clinically,
being acquainted with HLA distribution is a sine qua non for bone mar-
row donating centers [16,17], forensic medicine [18], studies of HLA re-
lated disease such as type 2 diabetes [19–21] or multiple sclerosis [22],
designing peptide vaccine and monoclonal antibodies against tumors
[23,24], infectious agents [25–27] and autoimmune disease [20,28], as
well as infertility treatment and assisted reproductive technologies
[29–31].-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Allele frequency of HLA-A and B in Lak population (our study) in comparison to total Ira-













A*01 8 9.25 B*07 4 4.75
A*02 18 18.16 B*08 4 4.25
A*03 12 12.08 B*13 4 3.91
4 F. Shahsavar et al. / Genomics Data 11 (2017) 3–6Race wise, Iran is a variable country that has different ethnicities
such as Kurd, Lur, Torkaman, Azeri, Arab and Balouch. Majority of Ira-
nians are Muslims, but Zoroastrians, Christians and Jewish also live in
this country [32]. History has it that the majority of Iranians are Aryan
but during the history they were attacked by different foreigners such
as Alexander and Macedonians, Arabs, Turks and Moguls [32]. As de-
scribed by a thesis under the supervision of Dr. Maziar Ashraﬁan
Bonab [33], Aryans are believed to be one of the early Proto-Indo-Euro-
pean speaking ethnicities migrated toward Iran. They arrived and set-
tled in the north of Afghanistan around 2000–1500 BCE and kept on
migrating and headed west settling in Iran and others south into India
and Pakistan. It seems that as a result of their vast distribution, the
Aryans were the main advocates of the Indo-European languages and
promoting their proliferation via cultural and demic diffusion and
therefore displacing the indigenous languages. Also Iran has played a
key role in connection of different populations via the Silk Road [34,
35]. Thus the living populations in this country might bemixed because
of migrations and mentioned relations.
Lak (or Laki) population is an ethnicity living in southwest of Iran
and southeast of Iraq that there is still a controversy whether they are
Kurd or Lur; because their culture and language are a complex of Kurd-
ish and Luri populations. Kurds, Lurs and Persians are accounted as
Indo-Iranian group of Aryans. The geographical condition of Laks
(Fig. 1) shows that the majority of Iranian Laks live in the north of
Lorestan province and some of them lives in Kermanshah, Ilam and
Hamadan [36].
In previous studies, allele frequency of HLA class-II were determined
in majority of different Iranian populations and compared with each
other [18,37]. In the present study, we intend to ﬁnd allele frequency
of HLA class-I in Lak/lᴂk/population of Lorestan province (west of
Iran) regarding to the lack of this study (on the class-I) in Lak popula-
tion. Then based on the HLA-I proﬁle the genetic relations between
this population and total Iranian population [38] is investigated.
2. Material and methods
For the present study, 100 healthy and unrelated Lak individuals liv-
ing in Lorestan provincewere randomly chosen by convenient sampling
based on the including criteria in 2015. Our including criteria was hav-
ing the same race (the two recent generations of each sample should be
Laks) and having 20–40 years of age, and the excluding criteriawas hav-
ing history of some speciﬁc diseases. Complete blood samples were ob-
tained with informed and written consents from the participating
individuals. The studywas approved by the ethic committee of Lorestan
University of Medical Sciences.Fig. 1. Geographical status of Laks (the red color) (adapted from the reference [36]).The genomic DNA of individuals was extracted by using kit BAG
(Germany). HLA-typing kit for polymerase chain reaction with se-
quence speciﬁc primer (PCR-SSP) – a method which has longer and
more speciﬁc primers for each allele of polymorphisms instead of
using restriction enzymes [39,40] –with low resolution (BAGGermany)
were used to determineHLA-A and B alleles via genomicDNA. PCR prod-
ucts got visible in 2% agarose gel including 0.5mg/ml EthidiumBromide
electrophoresis under an ultra violet light. Since there is a speciﬁc prim-
er for each allele in SSP method (and HLA is highly polymorphic), we
cannot write their sequences in the article and also it's a patent for the
company.
Allele frequencies of HLA-A and B were determined through the di-
rect countingmethod. The differences between the populations in allele
frequencies ofHLA-A and Bwere estimated by Chi-squared 2multiplied
by 2 test with degree of freedom 1. According to being multiple of
the compares, we used Yate's correction to correct the randomized
signiﬁcance. After the correction p b 0.05 considered as the level of
signiﬁcance.
3. Results
Allele frequency of HLA-A and B in Iranian Lak population are given
in Table 1. Fifteen allele for HLA-A and 23 allele for HLA-B were identi-
ﬁed. In Lak population, themost frequentHLA-A alleleswere respective-
ly A*24 (20%), A*02 (18%), A*3 (12%) andA*11 (10%). Themost frequent
HLA-B alleles were respectively B*35 (24%), B*51 (16%), B*18 (6%) and
B*38 (6%). The least frequent HLA-A alleles were A*66 (1%) and A*74
(1%) and the least frequentHLA-B alleles were B*48 (1%) and B*55 (1%).
4. Discussion
In the present study the most frequent HLA-A and HLA-B alleles in
100 healthy and unrelated Lak individuals were determinedwithmeth-
od PCR-SSP. Allele frequency of HLA-A and B in Lak and total Iranian
population [38] is shown in Table 1.A*11 10 10.41 B*14 2 3.00
A*23 2 2.25 B*15 2 3.16
A*24 20* 16.41 B*18 6 4.33
A*26 8 6.83 B*27 2 2.58
A*29 2 2.5 B*35 24* 21.66
A*30 6 4.66 B*37 2 1.00
A*31 6 6.16 B*38 6 4.33
A*32 2 5.66 B*39 2 0.91
A*33 2 3.66 B*40 4 3.58
A*43 – 0.16 B*41 3 2.75
A*66 1 0.25 B*42 – 0.165
A*68 2 4.16 B*44 2 4.165
A*69 – 0.16 B*45 – 0.165
A*74 1 0.41 B*47 – 0.165












High frequent alleles in different populations. X = not mentioned in reference [7] or the
frequency was b10% in spite of their high frequency.
Ethnicity High frequent alleles (N10%)
Laks A*02,03,11,24 B*35,51
Iranians A*02,03,11,24 B*35,51
Caucasians (the whites) of the USA A*01,02,03 B*04,44
The Lebanese A*01,02,24 B*35
Jordanians A*02 X
The Irish A*01,02 B*04,44
The Japanese A*02,24 B*52
Moroccans A*01,02 X
Koreans A*02,11,24 B*15
Africans A*23 X [B*35.53 [46]]
Bulgarians A*02,24 B*18,51
The Chinese A*11,24 B*46
Brazilians A*02,03,24 X [B*15,35,51 [44]]
Omanis A*02,11,26,32,68 B*51
The Polish A*01,02,03,24 X
The Spanish A*02 X
Armenians [47] A*01,02,03,24 B*35,51
5F. Shahsavar et al. / Genomics Data 11 (2017) 3–6As it is shown in Table 1, the frequency of the alleles HLA-A*24, HLA-
B*35 and HLA-B*51 in Lak population were signiﬁcantly more than the
frequency of these alleles in Iranian population.
In addition, comparing our ﬁndings with the ﬁndings of total Iranian
population study shows that allele frequency ofHLA-A and B in Lak pop-
ulation has a high similarity to total Iranian population. Recently, HLA
class I typing has been performed also in the Lur and Kurd populations
of western Iran [41]. Based on this study, A*24 and B*51 was high fre-
quent in both Lur and Kurd populations of Iran. Because their PCR kit
was high resolution, we could not statistically compare this study with
the study of ours.
Other than different Iranian populations and ethnicities, these ﬁnd-
ings are also similar to other studies on different white populations
(Table 2). In contrast, these ﬁndings are not similar to the ﬁndings of
Shen et al. in Han population of China [42] and Yao et al. in total Chinese
population [43] (except A*24, about 12% in the Chinese and 20% in Laks
that in the both populations was higher than 10% as the par of high fre-
quency). Of course this fact is reasonable through genetic similarity of
Iranians and others Caucasians and genetic difference between the
whites and yellow-skinned.
In a Brazilian population the most frequent alleles were A*02, A*03,
B*15, B*35, B*51 [44]. Alleles B*35 and B*51 high frequencywas like Lak
population, whereas B*15 is low frequent in Lak population. The allele
frequency of B*27 – which is associated with Ankylosing spondylitis
[45] – is low frequent in Lak population as other populations so. In Afri-
cans, alleles B*35 and B*53 were high frequent [46] as the Laks respec-
tively are and are not so. These ﬁndings suggest that some alleles like
A*24 are widespread in human race. As it's shown in Table 2 the high
frequent alleles (N10%) in different ethnicities [7] are compared with
Laks. Allele A*02 seems the most high frequent in different populations
(Table 2).
Analyzing frequency ofHLA-A and B alleles enable us to assay genetic
relations among various populations in our anthropological studies. As
well, determining allele frequency of HLA-A and B in Lak population
could be a good source for other studies in future such as correlations
between the alleles and genetic disorders.
5. Conclusions
At the end of the study, our results based on the allele frequencies
showed that the population has general features of the Lurs, the Kurds
and the total Iranian population reported before. Of course it's obvious
that themain conclusion is that establishing immunology-based labora-
tories is necessary to diagnose and treat diseases through molecular
methods. It could be useful for transplantation, assisted reproductive
technologies and HLA-related disease.Conﬂict of interest
Meanwhile we don't have conﬂict of interest.
Acknowledgements
Finally we take it upon ourselves to appreciate all the participants in
the study. Present study was performed under the ﬁnancial support of
Lorestan University of Medical Sciences with grant number 1139.
References
[1] A.D. Napier, Nonself help: how immunologymight reframe the enlightenment. Cult.
Anthropol. 27 (2012) 122–137.
[2] A. Cambrosio, P. Keating, A matter of FACS: constituting novel entities in immunol-
ogy. Med. Anthropol. Q. 6 (1992) 362–384.
[3] E. Martin, Toward an anthropology of immunology: the body as nation state. Med.
Anthropol. Q. 4 (1990) 410–426.
[4] M. PrabhuDas, E. Bonney, K. Caron, S. Dey, A. Erlebacher, A. Fazleabas, S. Fisher, T.
Golos, M. Matzuk, J.M. McCune, Immune mechanisms at the maternal-fetal inter-
face: perspectives and challenges. Nat. Immunol. 16 (2015) 328–334.
[5] S.A.Y. Ahmadi, F. Shahsavar, S. Akbari, A review on controversies about the role of
immune and inﬂammatory systems in implantation process and durability of preg-
nancy. Int. J. Womens Health Reprod. Sc. 4 (2016) 96–102.
[6] D.X. Beringer, F.S. Kleijwegt, F. Wiede, A.R. van der Slik, K.L. Loh, J. Petersen, N.L.
Dudek, G. Duinkerken, S. Laban, A. Joosten, J.P. Vivian, Z. Chen, A.P. Uldrich, D.I.
Godfrey, J. McCluskey, D.A. Price, K.J. Radford, A.W. Purcell, T. Nikolic, H.H. Reid,
T. Tiganis, B.O. Roep, J. Rossjohn, T cell receptor reversed polarity recognition of
a self-antigen major histocompatibility complex. Nat. Immunol. 16 (2015)
1153–1161.
[7] S. Khansa, R. Hoteit, D. Shammaa, R.A. Khalek, H. El Halas, L. Greige, F. Abbas, R.A.R.
Mahfouz, HLA class I allele frequencies in the Lebanese population. Gene 512 (2013)
560–565.
[8] S. Mukherjee, J. Warwicker, N. Chandra, Deciphering complex patterns of class-I
HLA–peptide cross-reactivity via hierarchical grouping. Immunol. Cell Biol. 93
(2015) 522–532.
[9] E.C. Castelli, T.H.A. Lima, R.V. Buttura, M.A. Paz, I.O.P. Porto, J. Ramalho, A.S. Souza,
L.C. Veiga-Castelli, C.T. Mendes-Junior, E.A. Donadi, Evaluation of the HLA-F variabil-
ity in Brazil by next generation sequencing. Hum. Immunol. 76 (2015) 89
(Supplement).
[10] E.C. Castelli, C.T. Mendes-Junior, A. Sabbagh, I.O.P. Porto, A. Garcia, J. Ramalho, T.H.A.
Lima, J.D. Massaro, F.C. Dias, C.V.A. Collares, V. Jamonneau, B. Bucheton, M. Camara,
E.A. Donadi, HLA-E coding and 3′ untranslated region variability determined by
next-generation sequencing in two West-African population samples. Hum.
Immunol. 76 (2015) 945–953.
[11] N. Lauterbach, L. Wieten, H.E. Popeijus, C.E.M. Voorter, M.G.J. Tilanus, HLA-E regu-
lates NKG2C+ natural killer cell function through presentation of a restricted pep-
tide repertoire. Hum. Immunol. 76 (2015) 578–586.
[12] T.D. Veit, J.A.B. Chies, M. Switala, B. Wagner, P.A. Horn, M. Busatto, C.V. Brenol, J.C.T.
Brenol, R.M. Xavier, V. Rebmann, The paradox of high availability and low recogni-
tion of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLoS
One 10 (2015), e0123838.
[13] A. Halenius, C. Gerke, H. Hengel, Classical and non-classical MHC I molecule manip-
ulation by human cytomegalovirus: so many targets—but how many arrows in the
quiver? Cell. Mol. Immunol. 12 (2015) 139–153.
[14] S.A.Y. Ahmadi, S. Akbari, F. Shahsavar, But the reverse is not true: a critical review on
staining protocol of uterine natural killer cells. J. Chem. Pharm. Sci. 9 (2016)
2483–2486 http://jchps.com/issues/jchps%209(4)%20140%20Seyyed%20Amir%
208%202483-2486.pdf.
[15] T. Mousavi, H. Poormoghim, M. Moradi, N. Tajik, F. Shahsavar, M. Sooﬁ, Phenotypic
study of natural killer cell subsets in ankylosing spondylitis patients. Iran. J. Allergy
Asthma Immunol. 8 (2009) 193–198.
[16] Z. Grubic, M.B. Kamenaric, M. Mikulic, K.S. Jankovic, M. Maskalan, R. Zunec, HLA-A,
HLA-B and HLA-DRB1 allele and haplotype diversity among volunteer bonemarrow
donors from Croatia. Int. J. Immunogenet. 41 (2014) 211–221.
[17] P.A. Gourraud, M.L. Balere, C. Faucher, P. Loiseau, A. Dormoy, E. Marry, F. Garnier,
HLA phenotypes of candidates for HSCT: comparing transplanted versus non-
transplanted candidates, resulting in the predictive estimation of the probability
to ﬁnd a 10/10 HLA matched donor. Tissue Antigens 83 (2014) 17–26.
[18] A.M. Varzi, F. Shahsavar, M.J. Tarrahi, Distribution of HLA-DRB1 and HLA-DQB1
alleles in Lak population of Iran. Hum. Immunol. 77 (7) (2016) 580–583.
[19] D.C. Chang, P. Piaggi, R.L. Hanson, W.C. Knowler, J. Bucci, G. Thio, M.G. Hohenadel, C.
Bogardus, J. Krakoff, Use of a high-density protein microarray to identify autoanti-
bodies in subjects with type 2 diabetes mellitus and an HLA background associated
with reduced insulin secretion. PLoS One 10 (2015), e0143551.
[20] N. Tajik, F. Shahsavar, H. Poormoghim, M. Radjabzadeh, T. Mousavi, A. Jalali,
KIR3DL1+ HLA-B Bw4Ile80 and KIR2DS1+ HLA-C2 combinations are both associ-
ated with ankylosing spondylitis in the Iranian population. Int. J. Immunogenet.
38 (2011) 403–409.
[21] M. Piga, A. Mathieu, Genetic susceptibility to Behcet's disease: role of genes belong-
ing to the MHC region. Rheumatology 50 (2011) 299–310.
[22] F. Shahsavar, S. Mapar, S.A.Y. Ahmadi, Multiple sclerosis is accompanied by lack of
KIR2DS1 gene: a meta-analysis. Genomics Data 10 (2016) 75–78.
6 F. Shahsavar et al. / Genomics Data 11 (2017) 3–6[23] S. Matsuoka, Y. Ishii, A. Nakao, M. Abe, N. Ohtsuji, S. Momose, H. Jin, H. Arase, K.
Sugimoto, Y. Nakauchi, Establishment of a therapeutic anti-pan HLA-class II mono-
clonal antibody that directly induces lymphoma cell death via large pore formation.
PLoS One 11 (2016), e0150496.
[24] W.D, M. Larche, Peptide-based therapeutic vaccines for allergic and autoimmune
diseases. Nat. Med. 11 (2005) 69–76.
[25] P.J. McLaren, M. Carrington, The impact of host genetic variation on infection with
HIV-1. Nat. Immunol. 16 (2015) 577–583.
[26] T. Mousavi, F. Shahsavar, P. Farnia, N. Tajik, M. Sooﬁ, Study of KIR expression and
HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients. Iran. J.
Allergy Asthma Immunol. 10 (2011) 189–194.
[27] F. Shahsavar, T. Mousavi, A. Azargon, K. Entezami, Association of KIR3DS1+ HLA-B
Bw4Ile80 combination with susceptibility to tuberculosis in Lur population of Iran.
Iran. J. Immunol. 9 (2012) 39–47.
[28] N. Hussain, G. Jaffery, Distribution of human leukocyte antigen alleles in systemic
lupus erythematosus patients with angiotensin converting enzyme insertion/dele-
tion polymorphism. Bosn. J. Basic Med. Sci. 13 (2013) 57–62.
[29] N. Alizadeh, E. Mosaferi, L. Farzadi, J. Majidi, A. Monfaredan, B. Youseﬁ, B. Baradaran,
Frequency of null allele of human leukocyte antigen-G (HLA-G) locus in subjects to
recurrent miscarriage. Int. J. Reprod. BioMed. 14 (2016) 459.
[30] M. Fotoohi, N. Ghasemi, S.A. Mirghanizadeh, M. Vakili, M. Samadi, Association be-
tween HLA-E gene polymorphism and unexplained recurrent spontaneous abortion
(RSA) in Iranian women. Int. J. Reprod. BioMed. 14 (2016) 477.
[31] T. Meuleman, L.E.L.O. Lashley, O.M. Dekkers, J.M.M. van Lith, F.H.J. Claas, K.W.M.
Bloemenkamp, HLA associations and HLA sharing in recurrent miscarriage: a sys-
tematic review and meta-analysis. Hum. Immunol. 76 (2015) 362–373.
[32] M. Mohebbi, Z. Mohebbi, Demography of race and ethnicity in Iran. The Internation-
al Handbook of the Demography of Race and Ethnicity, Springer 2015, pp. 353–366.
[33] J.W. Whale, Mitochondrial DNA Analysis of Four Ethnic Groups of Afghanistan. Uni-
versity of Portsmouth, 2012.
[34] P. Pollegioni, K.E. Woeste, F. Chiocchini, S. Del Lungo, I. Olimpieri, V. Tortolano, J.
Clark, G.E. Hemery, S. Mapelli, M.E. Malvolti, Ancient humans inﬂuenced the current
spatial genetic structure of common walnut populations in Asia. PLoS One 10
(2015), e0135980.
[35] B.I. Boulonois, The Silk Road. Allen & Unwin, London, 1966.
[36] E. Anonby, Kurdish or Luri, Laki's Disputed Identity in the Luristan Province of Iran.
Kurdische Studien. 4, 2004 7–22.
[37] O. M., S. Farjadian, H. Inoko, A. Ghaderi, The genetic relationship among Iranian eth-
nic groups: an anthropological view based on HLA class II gene polymorphism. Mol.
Biol. Rep. 36 (2009) 1943–1950.[38] A. Ghashghaie, K. Alimoghaddam, M.R. Ostadali, L. Khansari, M. Sadraee, E.
Mirrasekhian, I. Mohyedin, F. Raooﬁ, Z. Noori, H. Yaghmaian, Allele frequencies of
HLA class-I loci in the normal Iranian population. Int. J. Hematol. Oncol. Stem Cell
Res. 3 (2009) 18–20.
[39] W. De Spiegelaere, J. Philippé, K. Vervisch, C. Verhofstede, E. Malatinkova, M.
Kiselinova, W. Trypsteen, P. Bonczkowski, D. Vogelaers, S. Callens, Comparison of
methods for in-house screening of HLA-B* 57: 01 to prevent abacavir hypersensitiv-
ity in HIV-1 care. PLoS One 10 (2015), e0123525.
[40] N. Tajik, F. Shahsavar, M. Nasiri, M. Radjabzadeh, Compound KIR-HLA genotype
analyses in the Iranian population by a novel PCR–SSP assay. Int. J. Immunogenet.
37 (2010) 159–168.
[41] E. Ashouri, P. Norman, L. Guethlein, A. Han, N. Nemat-Gorgani, S. Norberg, A.
Ghaderi, P. Parham, HLA class I variation in Iranian Lur and Kurd populations:
high haplotype and allotype diversity with an abundance of KIR ligands. HLA 88
(2016) 87–99.
[42] Y.S. Shen, D.F. Cao, Y.L. Li, J.K. Kulski, L. Shi, H.J. Jiang, Q.L. Ma, J.K. Yu, J.X. Zhou, Y.F.
Yao, L. Shi, Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in
Han Population in China. J. Immunol. Res. (2014) (https://www.hindawi.com/
journals/jir/2014/565296/).
[43] Y. Yao, L. Shi, Y. Tao, J.K. Kulski, K. Lin, X. Huang, H. Xiang, J. Chu, L. Shi, Distinct HLA
allele and haplotype distributions in four ethnic groups of China. Tissue Antigens 80
(2012) 452–461.
[44] C. Rodrigues, L.C. Macedo, A.V. Bruder, F.D.C. Quintero, J.B. de Alencar, A.M. Sell, J.E.L.
Visentainer, Allele and haplotype frequencies of HLA-A, B, C, DRB1 and DQB1 genes
in polytransfused patients in ethnically diverse populations from Brazil. Int. J.
Immunogenet. 42 (2015) 322–328.
[45] I. El Mouraghi, A. Ouarour, I. Ghozlani, E. Collantes-Estevez, R. Solana, A. El
Maghraoui, Polymorphisms of HLA-A, -B, -Cw and DRB1 antigens in Moroccan pa-
tients with ankylosing spondylitis and a comparison of clinical features with fre-
quencies of HLA-B*27. Tissue Antigens 85 (2015) 108–116.
[46] P.J. Norman, J.A. Hollenbach, N. Nemat-Gorgani, L.A. Guethlein, H.G. Hilton, M.J.
Pando, K.A. Koram, E.M. Riley, L. Abi-Rached, P. Parham, Co-evolution of human leu-
kocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors
(KIR) in a genetically diverse population of Sub-Saharan Africans. PLoS Genet. 9
(2013).
[47] L. Matevosyan, S. Chattopadhyay, V. Madelian, S. Avagyan, M. Nazaretyan, A.
Hyussian, E. Vardapetyan, R. Arutunyan, F. Jordan, HLA-A, HLA-B, and HLA-DRB1 al-
lele distribution in a large Armenian population sample. Tissue Antigens 78 (2011)
21–30.
